Expert consensus on the use of trazodone in patients with major depressive disorder: Results from a European Delphi panel
Background: Trazodone is commonly used in the treatment of major depressive disorder (MDD) in adults.This study aimed to establish consensus on the clinical scenarios and patient profiles for which trazodone treatment is considered suitable.Methods: A two-round Delphi process was conducted across eight European countries.
Authors
- Agüera-Ortiz Lf
- Allan Hunter Young
- Marcin Siwek
- Andrea Fagiolini
- Siegfried Kasper
Institutions
- University of Siena (IT)
- Jagiellonian University (PL)
- King's College London (GB)
- Hospital Universitario 12 De Octubre (ES)
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Psychiatry
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1192/j.eurpsy.2026.10162
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Biogen
- Sunovion
- LivaNova
- Mylan
- University of Cambridge
- Gedeon Richter
- Eisai
- Angelini Pharma
- Servier
- H. Lundbeck A/S
- Italfarmaco
- Bausch Health
- Idorsia Pharmaceuticals
- Allergan